Belgium· BE-AMP-SAM004076-00

Aureomycin 1 %

A chlortetracycline product containing chlortetracycline hydrochloride, registered in Belgium by BePharBel Manufacturing. The same ATC class is registered in 4 of our 19 countries.

ATC S01AA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAureomycin 1 %ATCS01AA02REGISTER NO.BE-AMP-SAM004076-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Chlortetracycline is registered in 4 of 19 countries.

Countries holding a registration under ATC S01AA02 (chlortetracycline), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 3 of them publish a price we can compare per daily dose

Chlortetracycline · ATC S01AA02

4 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Chlortetracycline Hydrochloride
Manufacturer
BePharBel Manufacturing
Country
Belgium (BE)
ATC code
S01AA02
ATC class
Chlortetracycline
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0102053

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Chlortetracycline in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlortetracycline products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Germany · Aureomycin
  • Spain · Dermosa Aureomicina, Oftalmolosa Cusí Aureomicina
  • France · Aureomycine Evans
  • Italy · Aureomicina
  • Luxembourg · Aureomycin
  • Poland · Chlorocyclinum 3 %

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cfc7c470-392b-4e53-a293-b53ea5de4e92
GET /v1/drugs/cfc7c470-392b-4e53-a293-b53ea5de4e92?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye ointment",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Aureomycin 1 %",
  "name_fr": "Aureomycin 1 %",
  "name_nl": "Aureomycin 1 %",
  "amp_code": "SAM004076-00",
  "strengths": [
    "10.0000",
    "100.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Chlortetracycline Hydrochloride",
    "Wool Fat"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Chlortetracycline",
  "authorisation_numbers": [
    "BE004076"
  ]
}

See everything about chlortetracycline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.